VivoSim Labs, Inc. Other Asset Impairment Charges
VivoSim Labs, Inc. (VIVS) reported Other Asset Impairment Charges of $0 for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-01-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2012-01-17
- VivoSim Labs, Inc. other asset impairment charges for the quarter ending 2011-12-31 was $0.00.
- VivoSim Labs, Inc. other asset impairment charges for the quarter ending 2011-09-30 was $0.00.
- VivoSim Labs, Inc. other asset impairment charges for the quarter ending 2010-12-31 was $0.00.
- VivoSim Labs, Inc. other asset impairment charges for the quarter ending 2010-09-30 was $0.00.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 21 month | Other Asset Impairment Charges 24 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 10-Q · filed 2012-01-17 | $0.00 10-Q · filed 2012-01-17 | $27.72K 10-Q · filed 2012-01-17 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-10-31 | $27.72K 10-Q · filed 2011-10-31 | ||
| 2010-12-31 | $0.00 10-Q · filed 2012-01-17 | $0.00 10-Q · filed 2012-01-17 | ||
| 2010-09-30 | $0.00 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |